The Plasminogen Fibrinolytic Pathway Is Required for Hematopoietic Regeneration

Cell Stem Cell

Volumn 1, Issue 6, 2007, Pages 658-670

  Heissig, Beate ^a,b   Lund, Leif R ^c   Akiyama, Haruyo ^a   Ohki, Makiko ^a   Morita, Yohei ^a   Rømer, John ^c   Nakauchi, Hiromitsu ^a   Okumura, Ko ^b   Ogawa, Hideoki ^b   Werb, Zena ^d   Danø, Keld ^c   Hattori, Koichi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FINSEN LABORATORY   (Denmark)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

STEMCELL

Indexed keywords

ALTEPLASE; MATRIX METALLOPROTEINASE; PLASMINOGEN; STEM CELL FACTOR; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL REGENERATION; CELL STRESS; CONTROLLED STUDY; ENZYME RELEASE; FIBRINOLYSIS; GENE ACTIVATION; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FIBRINOLYSIS; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; PLASMINOGEN; SIGNAL TRANSDUCTION; STEM CELL FACTOR;

MUS;

EID: 36749045144     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2007.10.012     Document Type: Article

References (30)

1. Andersen H.R., Nielsen T.T., Rasmussen K., Thuesen L., Kelbaek H., Thayssen P., Abildgaard U., Pedersen F., Madsen J.K., Grande P., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N. Engl. J. Med. 349 (2003) 733-742
2. Andreasen P.A., Egelund R., and Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57 (2000) 25-40
3. Andrews R.G., Bartelmez S.H., Knitter G.H., Myerson D., Bernstein I.D., Appelbaum F.R., and Zsebo K.M. A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons. Blood 80 (1992) 920-927
4. Barker J.E. Sl/Sld hematopoietic progenitors are deficient in situ. Exp. Hematol. 22 (1994) 174-177
5. Barker J.E. Early transplantation to a normal microenvironment prevents the development of Steel hematopoietic stem cell defects. Exp. Hematol. 25 (1997) 542-547
6. Bugge T.H., Flick M.J., Daugherty C.C., and Degen J.L. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9 (1995) 794-807
7. Camiolo S.M., Thorsen S., and Astrup T. Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin. Proc. Soc. Exp. Biol. Med. 138 (1971) 277-280
8. Cheng T., Petraglia A.L., Li Z., Thiyagarajan M., Zhong Z., Wu Z., Liu D., Maggirwar S.B., Deane R., Fernandez J.A., et al. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat. Med. 12 (2006) 1278-1285
9. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
10. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., Hicklin D.J., Zhu Z., Witte L., Crystal R.G., et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193 (2001) 1005-1014
11. Hattori K., Heissig B., Wu Y., Dias S., Tejada R., Ferris B., Hicklin D.J., Zhu Z., Bohlen P., Witte L., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8 (2002) 841-849
12. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., Crystal R.G., Besmer P., Lyden D., Moore M.A., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
13. Heissig B., Hattori K., Friedrich M., Rafii S., and Werb Z. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr. Opin. Hematol. 10 (2003) 136-141
14. Heissig B., Ohki Y., Sato Y., Rafii S., Werb Z., and Hattori K. A role for niches in hematopoietic cell development. Hematology 10 (2005) 247-253
15. Heissig B., Rafii S., Akiyama H., Ohki Y., Sato Y., Rafael T., Zhu Z., Hicklin D.J., Okumura K., Ogawa H., et al. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J. Exp. Med. 202 (2005) 739-750
16. Hellman S., and Grate H.E. Haematopoietic stem cells: evidence for competing proliferative demands. Nature 216 (1967) 65-66
17. Herren T., Swaisgood C., and Plow E.F. Regulation of plasminogen receptors. Front. Biosci. 8 (2003) d1-d8
18. Hu K., Yang J., Tanaka S., Gonias S.L., Mars W.M., and Liu Y. Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J. Biol. Chem. 281 (2006) 2120-2127
19. Huang E., Nocka K., Beier D.R., Chu T.Y., Buck J., Lahm H.W., Wellner D., Leder P., and Besmer P. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63 (1990) 225-233
20. Kijima T., Maulik G., Ma P.C., Tibaldi E.V., Turner R.E., Rollins B., Sattler M., Johnson B.E., and Salgia R. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res. 62 (2002) 6304-6311
21. Lagasse E., and Weissman I.L. Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods 197 (1996) 139-150
22. Lijnen H.R., Silence J., Lemmens G., Frederix L., and Collen D. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb. Haemost. 79 (1998) 1171-1176
23. Lijnen H.R., Van Hoef B., Lupu F., Moons L., Carmeliet P., and Collen D. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1035-1045
24. Liu Z., Li N., Diaz L.A., Shipley M., Senior R.M., and Werb Z. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J. Clin. Invest. 115 (2005) 879-887
25. Lund L.R., Green K.A., Stoop A.A., Ploug M., Almholt K., Lilla J., Nielsen B.S., Christensen I.J., Craik C.S., Werb Z., et al. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J. 25 (2006) 2686-2697
26. Selvarajan S., Lund L.R., Takeuchi T., Craik C.S., and Werb Z. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat. Cell Biol. 3 (2001) 267-275
27. Socolovsky M., Nam H., Fleming M.D., Haase V.H., Brugnara C., and Lodish H.F. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98 (2001) 3261-3273
28. Suelves M., Lopez-Alemany R., Lluis F., Aniorte G., Serrano E., Parra M., Carmeliet P., and Munoz-Canoves P. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood 99 (2002) 2835-2844
29. Wilcox R.G. Clinical trials in thrombolytic therapy: what do they tell us? INJECT 6-month outcomes data. Am. J. Cardiol. 78 (1996) 20-23
30. Zou T., Ling C., Xiao Y., Tao X., Ma D., Chen Z.L., Strickland S., and Song H. Exogenous tissue plasminogen activator enhances peripheral nerve regeneration and functional recovery after injury in mice. J. Neuropathol. Exp. Neurol. 65 (2006) 78-86